Publicacións nas que colabora con Urbano Anido Herranz (13)

2023

  1. Clinical, molecular, and immune correlates of the Immunotherapy Response Score in patients with advanced urothelial carcinoma under atezolizumab monotherapy: analysis of the phase II IMvigor210 trial

    ESMO Open, Vol. 8, Núm. 4

2021

  1. Clinical potential of circulating free DNA and circulating tumour cells in patients with metastatic non-small-cell lung cancer treated with pembrolizumab

    Molecular Oncology, Vol. 15, Núm. 11, pp. 2923-2940

  2. Longitudinal CTCs gene expression analysis on metastatic castration-resistant prostate cancer patients treated with docetaxel reveals new potential prognosis markers

    Clinical and Experimental Metastasis, Vol. 38, Núm. 2, pp. 239-251

  3. Rethinking prognostic factors in locally advanced or metastatic urothelial carcinoma in the immune checkpoint blockade era: a multicenter retrospective study

    ESMO open, Vol. 6, Núm. 2, pp. 100090

2020

  1. Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?

    Journal of Chemotherapy, pp. 1-13

  2. Global gene expression characterization of circulating tumor cells in metastasic castration-resistant prostate cancer patients

    Journal of Clinical Medicine, Vol. 9, Núm. 7, pp. 1-14

2017

  1. Development of de novo psoriasis during nivolumab therapy for metastatic renal cell carcinoma: immunohistochemical analyses and clinical outcome

    APMIS

2016

  1. Long-term response to nivolumab and acute renal failure in a patient with metastatic papillary renal cell carcinoma and a PD-L1 tumor expression increased with sunitinib therapy: A case report

    Frontiers in Oncology, Vol. 6, Núm. NOV

2013

  1. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer

    Oncology Reports, Vol. 29, Núm. 6, pp. 2467-2472

2012

  1. A logistic model for the detection of circulating tumour cells in human metastatic colorectal cancer

    Journal of Cellular and Molecular Medicine, Vol. 16, Núm. 10, pp. 2342-2349

2011

  1. High-risk endometrial carcinoma profiling identifies TGF-β1 as a key factor in the initiation of tumor invasion

    Molecular Cancer Therapeutics, Vol. 10, Núm. 8, pp. 1357-1366

2009

  1. Brain metastases from prostate adenocarcinoma

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 63-64

2007

  1. Tumoración en la encía en un paciente con antecedentes de cirrosis hepática

    Revista Clinica Espanola, Vol. 207, Núm. 7, pp. 365-366